Medovex Corp. Class A Warrant
MDVXW
MDVXW was delisted on the 14th of November, 2017.
2 hedge funds and large institutions have $1K invested in Medovex Corp. Class A Warrant in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.09K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$488 |
MDVXW Hedge Fund Activity: Q1 2016 in Review
2 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Medovex Corp. Class A Warrant (MDVXW) for Q1 2016, worth a combined $1K.
Buyers outnumbered sellers: 1 fund opened new MDVXW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.09K. The largest seller was UBS Group, cutting an estimated $488.
- 2 institutional investors held Medovex Corp. Class A Warrant (MDVXW) as of Q1 2016, up from 1 in Q4 2015.
- Funds reported $1K of Medovex Corp. Class A Warrant stock for Q1 2016.
- 1 fund opened new Medovex Corp. Class A Warrant positions in Q1 2016 and 0 closed out, a net change of +1 holder.
- The largest Medovex Corp. Class A Warrant buyer in Q1 2016 was Susquehanna International Group, an estimated $1.09K added.
- The largest Medovex Corp. Class A Warrant seller in Q1 2016 was UBS Group, an estimated $488 sold.
Based on aggregated 13F filings for Q1 2016.